Business
Press Release Jun 14 2021
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS��) in the US market".
About this update from Natco Pharma Limited
[{"type":"text","content":" Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled \"NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS��) in the US market\". View Attachment","length":343,"tagName":"div"}]